Sysmex's History (Overview)

Sysmex's History1960

Taro Nakatani, then Vice President of a leading megaphone manufacturer TOA ELECTRIC CO., LTD. (presently TOA Corporation), traveled to the United States in search of a new pillar of business.

Sysmex's History1961

TOA ELECTRIC CO., LTD. decided to enter the medical electronics industry.

History of our products1963

Successfully commercialized the automated hematology analyzer CC-1001, the first blood cell counter in Japan.

Sysmex's History1965

Founder Taro Nakatani announced the corporate attitude of “Selling the Results”

History of our products1966

Provision of scientific services

The company began publishing MCC News for hospital laboratories across Japan (MCC is an acronym for “micro cell counter.”)

History of our products1967

Company began providing diagnostic reagents

To measure blood cells, both instruments and reagents are needed. To deliver accurate counting results to customers, even though it is an equipment manufacturer the Company made the decision to begin providing reagents.
(The first reagents the Company developed: Cellkit, a diluent, and Saponin S, a lysing reagent)

Sysmex's History1967

TOA ELECTRIC CO., LTD., launched the ME Instrument Department
(ME stands for “medical electronic instruments”)

Sysmex's History1968

Establishment as a sales company

TOA MEDICAL ELECTRONICS CO., LTD. was founded to sell medical electronic equipment manufactured by TOA ELECTRIC CO., LTD. Taro Nakatani appointed as the first president.

Taro Nakatani advanced a new fundamental management policy, the “Three Aspects of Confidence”
(Current founding philosophy)

History of our products1968

Company began providing standard reference substance for use in quality control, in the aim of increasing the reliability of counting results

The Company begins selling CELLCHECK-B, a standard reference substance that includes a defined number of blood cells, allowing laboratories to confirm the accuracy of their cell measurements.

Sysmex's History1972

Establishment of first overseas location (Hamburg, Germany)

Sysmex's History1973

Transition from a sales company to a specialized manufacturer of clinical testing instruments (integrated manufacturing and sales)

The Company established the Kakogawa Factory and integrated the Sales, Development, Production and General Affairs divisions.
(Kakogawa, Hyogo Prefecture)

Sysmex's History1974

Proposal of a stance outlining the pursuit of quality

Taro Nakatani addressed all employees, emphasizing that “Quality is our heart: the company's means to life.”

History of our products1974

Entry into the urinalysis field

The Company launched the TU-100, a simplified automated urinalysis analyzer.

History of our products1975

Introduction of Japan's first fully automated hematology analyzer
(The automated hematology analyzer CC-710)

Sysmex's History1977

Start of entry into the world’s largest market (San Francisco, United States)

Sysmex's History1978

The birth of the Sysmex brand

The product brand transitions from TOA to Sysmex.

History of our products1978

Holding of the first hematology seminar

The Company put on a full-fledged seminar with the goal of “providing up-to-date information about hematology, and being of use around the world.”
Since that time, seminar themes have also expanded beyond hematology, and have continued as “scientific seminars.”

History of our products1979

Achievement of fully automated processing of hematology testing

The Company launched the world’s first fully automated blood cell counter featuring a sampler, the CC-720.

Sysmex's History1979

Establishment of first overseas subsidiary (Los Angeles, United States)

The Company established TOA MEDICAL ELECTRONICS (USA) INC. (presently Sysmex America, Inc.)

Sysmex's History1980

Establishment of European subsidiary (Hamburg, Germany)

The Company established TOA MEDICAL ELECTRONICS (DEUTSCHLAND) GMBH (presently Sysmex Europe SE).

History of our products1983

Use of “sheath flow” to enhance measurement precision and increase in the clinical value of counting results through three-part white blood cell differentiation

The Company launched the E-Series automated hematology analyzer.

History of our products1984

Entry into the hemostasis field

The Company launched the CA-100, its first automated blood coagulation analyzer.

Sysmex's History1986

Enhancement of R&D structure in the hemostasis, immunochemistry and urinalysis fields

The Company established the Kobe factory in the Seishin Industrial Park and relocated the R&D division (Kobe, Hyogo Prefecture/ presently Technopark)

History of our products1987

Entry into the immunochemistry field

Launched the PAMIA-10 automated immunochemical analyzer, which used our proprietary immunoassay method to measure tiny amounts of protein in serum.

Sysmex's History1988

Reizo Hashimoto was appointed president and stated “Within 10 years, we will become the global leader in the hematology field.” and “We aim for new business to account for more than 40% of sales.”

History of our products1988

The Company launched the automated reticulocyte analyzer R-1000, the world’s first instrument to automatically measure reticulocytes.

History of our products1990

The Company launched the HS-Series integrated hematology system, the world’s first fully automated system handling blood cell counts, white blood cell differentiation, reticulocyte measurement and preparation of smear samples.

Entry into the sediment urinalysis field with products developed in-house

The Company launched the automated urine sediment analyzer UA-1000.

Sysmex's History1991

Establishment of its first reagent factory in Japan (Ono, Hyogo Prefecture)

Commencement of direct sales, service and support for the first time overseas (United Kingdom)

TOA MEDICAL ELECTRONICS (UK) LTD. (presently Sysmex UK Limited)

Sysmex's History1993

Start of reagent production overseas (Germany)

The Company established a reagent production base, Neumünster Factory.

Establishment of U.S. reagent production base, SYSMEX CORPORATION OF AMERICA (presently Sysmex Reagents America, Inc.)

Sysmex's History1994

Start of developing an operating base in the Asia Pacific region

The Company established the Singapore representative office.

Sysmex's History1995

Accelerated business expansion in the hemostasis field

The Company concluded a business collaboration agreement with Dade International Inc. (presently Siemens Healthcare Diagnostics Inc.) regarding the sale of coagulation product lines.

Establishment of a reagent supply and technical service structure in China

The Company established a joint venture (presently Jinan Sysmex Medical Electronics Co., Ltd.) in Jinan, China.

History of our products1995

Launch of the SF-3000 automated multiparameter hematology analyzer, combining a semiconductor laser and flow cytometry technology

The Company promoted the spread of white cell differentiation instruments among small and medium-sized laboratories.

Toward the provision of total solutions in clinical testing

The Company launched a laboratory information system.

Sysmex's History1995

Shares listed on the Second Section of the Osaka Securities Exchange

The Company strengthened the management structure through various activities towards its listings. (listing on the Second Section of the Tokyo Stock Exchange in 1996 and the First Sections of the Tokyo and Osaka exchanges in 2000)

History of our products1995

Launch of the UF-100 fully automated analyzer of formed elements in urine, the world’s first fully automated instrument for sediment urinalysis testing

Sysmex's History1996

Hisashi Ietsugu (current Chairperson and Group CEO) was appointed president and stated “We aim to transform the company from a specialized manufacturer to a distinctive and global comprehensive manufacturer.”

Sysmex's History1998

Establishment of regional headquarters for the Asia Pacific region

SYSMEX SINGAPORE PTE LTD. (presently Sysmex Asia Pacific Pte Ltd.)

Strengthening of the global sales network through business alliances with a leading global healthcare company

Alliance with F. Hoffmann-La Roche Ltd. (Switzerland) in hematology products

Establishment of a regional headquarters in China

Commencement of reagent production in India
The Company established the joint venture SYSMEX TRANSASIA BIO-MEDICALS PRIVATE LTD. (presently Sysmex India Pvt. Ltd.).

Change of the name to Sysmex Corporation, relocation of head office on the occasion of the 30th anniversary of establishment

History of our products1999

Launch of the XE-2100 automated multiparameter hematology analyzer

In 2007, the Company becomes the global leader in the hematology field.

Enhancement of service quality through the online provision of external quality control

The Company began providing Sysmex Network Communication Systems (SNCS), an online support service.

Sysmex's History2000

Establishment of a regional headquarters in China

Establishment of Sysmex Shanghai Ltd.

Expansion of the global production system to ensure a stable supply of reagents

The Company began producing reagents at subsidiaries in Brazil and Singapore.

Beginning to take on the challenge of the life science field

The Company established the Central Research Laboratories at Techno Center (presently Technopark)
(Kobe, Hyogo Prefecture)

Sysmex's History2002

Reinforcement of R&D capabilities for the production of bio-diagnostic reagents

International Reagents Corporation became a wholly owned subsidiary. (Absorbed into Sysmex Corporation in 2022)

Sysmex's History2003

Commencement of direct sales and service in the United States

History of our products2006

Contribution to improvements in patients’ quality of life through the realization of intraoperative rapid detection of lymph node metastasis of breast, colorectal and stomach cancers

In Europe, Sysmex launches its first product in the life science business: the RD-100i gene amplification detector and LYNOAMP BC, a related reagent.

Sysmex's History2007

Formulation of “Sysmex Way,” the corporate philosophy for the Sysmex Group

History of our products2007

Launch of the HISCL-2000i fully automated immunoassay system, realizing highly sensitive, high-speed testing of minute samples due to the development of the chemiluminescence enzyme immunoassay (CLEIA) method

Sysmex's History2008

Updating of the corporate logo on the occasion of the 40th anniversary of establishment

Opening of Technopark, the Company’s core R&D base, under the concept of the “Creation of ‘knowledge’ and its inheritance”

History of our products2011

Global launch of the XN-Series, our flagship model in the hematology field, aiming to establish our position as the undisputed global leader in hematology

Launch of the CS-5100 fully automated blood coagulation analyzer, a new model in the hemostasis field offering enhanced processing capacity

History of our products2012

Contribution to the realization of increased testing efficiency and pre-examination testing through fast measurement requiring only 17 minutes and advanced functionality

The Company launched the HISCL-5000 fully automated immunoassay system, a new model in the immunochemistry testing field.

Sysmex's History2013

Entry into the medical robotics market

Sysmex jointly established Medicaroid Corporation with Kawasaki Heavy Industries, Ltd., as a marketing company toward the development of medical robots.

Acceleration of developing technology platforms toward personalized medicine

Sysmex acquired Partec GmbH (presently Sysmex Partec GmbH) of Germany, a pioneer in FCM technology.

Sysmex acquired Inostics GmbH (presently Sysmex Inostics GmbH), which possesses technology for the highly sensitive measurement of cancer genes in the blood.

Sysmex's History2014

Entry into the lab assay business for gene testing

Sysmex became an equity participant in RIKEN GENESIS Co., Ltd., to promote advances in the gene testing business.

Reconfiguration of instrument manufacturing system aimed at high “made-in-Japan” quality.

Sysmex opened i-Square, its core instrument factory. (Kakogawa, Hyogo Prefecture)

History of our products2015

Sysmex launched UF-5000 fully automated analyzer of formed elements in urine, next-generation models in the field of sediment urinalysis testing.

Sysmex's History2017

Expansion of portfolio in the life science business

Sysmex acquired Oxford Gene Technology IP Limited, which possesses unique genetic analysis technologies.

History of our products2018

Sysmex launched Caresphere™, a new network solution.

Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19

Sysmex Launches New Products in the Hemostasis Field: Automated Blood Coagulation Analyzers CN-6000 and CN-3000

History of our products2019

Commencement of assay service using the OncoGuide™ NCC Oncopanel System in cancer genome profiling

Sysmex's History2019

Strengthening of diagnostic reagent capabilities to support business expansion.

Opened Technopark East Site, a bio-diagnostic reagent base located within Technopark (Kobe, Hyogo Prefecture)

Sysmex's History2020

Jointly established D’PULA Medical Solutions Corporation with OPTiM Corporation.

History of our products2020

Launched the hinotori Surgical Robot System, a surgical robot unit.

History of our products2021

Launched its next-generation flagship model in the hematology field, the XR-Series Automated Hematology Analyzer.

Sysmex's History2022

Acceleration of the clinical application of the rapid antimicrobial susceptibility test

Sysmex Astrego AB became a subsidiary.

History of our products2022

Launched the UF-1500 Fully Automated Urine Particle Analyzer, a new product for use in urine sediment testing.

Sysmex's History2022

Established a joint venture, AlliedCel, with the co-founder JCR Pharmaceuticals Co., Ltd.

History of our products2023

Sysmex launched an assay kit to identify amyloid beta (Aβ) accumulation in the brain, a cause of Alzheimer’s disease, using a small amount of blood: the HISCL β-Amyloid 1-40 assay kit.

Sysmex's History2023

Accelerated co-creation with diverse external partners

Established the new open innovation hub “Healthcare Science Hub Tokyo“.

Accelerated initiatives in regenerative and cellular medicine

Megakaryon Corporation became a subsidiary.

Sysmex's History2024

Established a diagnostic reagents and instrument manufacturing base in Gujarat, India.